SpaceX~$1TSpaceX~$1T
Insider Buying
Subscribe
All stock lists
NIKI

Niki BioSolutions, Inc. (NIKI)

NASDAQ: NIKI · Real-Time Price · USD
Healthcare · Biotechnology
$1.50-$0.20 (-11.76%)
 
Market cap
$4.68M
Insider Score
Market Cap$4.68M-88.9%
Revenue (ttm)n/a
Net Income-$2.25M
EPS-$2.90
Shares Out2.94M
PE Ration/a
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume4,987
Open$1.71
Previous Close$1.70
Day's Range$1.50 - $1.71
52-Week Range$1.42 - $17.20
Beta-0.80
Analystsnone
Price Targetn/a
Earnings Daten/a
-11.76% (1D)
No price history available.

About NIKI

Niki BioSolutions, Inc., through its subsidiaries, operates as a clinical-stage biopharmaceutical company and engages in the discovery, development, and commercialization of therapeutic products to treat oncology and infectious diseases. Its pipeline products include SACT-1, a repurposed drug candidate, which is in a Phase 1 clinical trial to treat neuroblastoma and other cancer types; ALS-4, a repurposed small molecule, which is in a Phase 1 clinical trial for the treatment of bacterial infections, such as staphylococcus aureus, mycobacterium tuberculosis, and pseudomonas aeruginosa. The company also develops SACT-COV19, a repurposed small molecule, which is in a preclinical trial for the treatment of coronavirus disease; SACT-2 and SACT-3; ALS-1, a small molecule, which is in a preclinical trial to treat bacterial infections caused by staphylococcus aureus, including methicillin-resistant staphylococcus aureus (MRSA); and ALS-2/3, a small molecule, which is in a preclinical trial for the treatment of gram+ve bacterial infections. The company was formerly known as Aptorum Group Limited and changed its name to Niki BioSolutions, Inc. in July 2026. Niki BioSolutions, Inc. was incorporated in 2010 and is headquartered in Princeton, New Jersey. Niki BioSolutions, Inc. operates as a subsidiary of Jurchen Investment Corporation.

Address
116 Village Boulevard, Princeton, NJ, 08540, United States
Market Cap
5 million
Employees
1
Industrial Classification
Biotechnology
1 Day
-11.76%
5 Days
-6.83%
1 Month
-27.88%
6 Months
-82.14%
1 Year
-88.89%

$NIKI stock is featured in our Insider Trades datasets.

→ All Stock Lists

Recently reported changes in NIKI holdings by institutional investors

Scanning latest 13F filings…

Latest 0 13F filings · Source: SEC EDGAR

View all institutional owners →

Insider Trading

Quarterly net insider trading by NIKI's directors and management

Net Shares Purchased by Insiders−1−102025Q42026Q12026Q22026Q32026Q4

Source: SEC EDGAR (Form 4)

Corporate Lobbying

NIKI Estimated quarterly lobbying spending

Source: U.S. Senate LDA

U.S. Patents

New NIKI patent grants

Loading patent grants…

Source: USPTO Open Data Portal

Government Contracts

Estimated quarterly amount awarded to NIKI from public contracts

Source: USAspending.gov

Bull Case vs Bear Case

AI-generated from NIKI’s recent data — informational, not investment advice

Generating analysis…

Recent Insider Activity

Buys
0
Sells
0
Buy Value
$0
Distinct Buyers
0

Frequently Asked Questions

Disclaimer — Informational only — not investment advice. Insider transaction data is sourced from SEC Form 4 filings; market data from public feeds and may be delayed. The Insider Score is a proprietary score for research purposes and does not predict future performance. Always do your own research.